Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit

Neurology

Volumn 58, Issue 9, 2002, Pages 1372-1381

  Silber, Eli ^a   Semra, Y K ^a   Gregson, N A ^a   Sharief, M K ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G; NEUROFILAMENT PROTEIN; TUBULIN;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; NEUROFILAMENT; PRIORITY JOURNAL;

EID: 0037076504     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.58.9.1372     Document Type: Article

References (25)

1. Rachelle Fishman-Matthew Moore Lecture. The pathological and clinical dynamics of multiple sclerosis
2. Demyelinating diseases-new pathological insights, new therapeutic targets
3. Immunopathology of multiple sclerosis: Report on an international meeting held at the Institute of Neurology of the University of Vienna
4. The path to damage in multiple sclerosis
5. A structural scaffolding of intermediate filaments in health and disease
6. Neurofilament function and dysfunction: Involvement in axonal growth and neuronal disease
7. Reduced diameter and conduction velocity of myelinated fibers in the sciatic nerve of a neurofilament-deficient mutant quail
8. Motor neurons and neurofilaments in sickness and health
9. Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament proteins in CSF
10. Neurofilament protein in cerebrospinal fluid: A potential marker of activity in multiple sclerosis
11. Tubulin synthesis and assembly in differentiating neurons
12. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells
13. Modulation of the axonal microtubule cytoskeleton by myelinating Schwann cells
14. Axonal transection in the lesions of multiple sclerosis
15. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
16. Defining the clinical course of multiple sclerosis: Results of an international survey
17. Rating neurological impairment in multiple sclerosis: An expanded disability status scale (EDSS)
18. Neuromodulatory loop mediated by nerve growth factor and interleukin 6 in thymic stromal cell cultures
19. Circulating autoantibodies to the 200,000-dalton protein of neurofilaments in the serum of healthy individuals
20. Autoantibodies in neurodegenerative diseases: Antigen-specific frequencies and intrathecal analysis
21. Axonal dystrophy as a consequence of long-term demyelination
22. Probing for cerebrospinal fluid antibody specificities by a panel of random peptide libraries
23. Autoimmunity to ion-channels and other proteins in paraneoplastic disorders
24. Neurofilament is an autoantigenic determinant in myasthenia gravis
25. Human monoclonal antineurofilament antibody cross-reacts with a neuronal surface protein